Skip to content

Next-Gen MS: Feed-forward PRO Data for MS Research

Next-Gen MS: A Prospective, Cluster-randomized Study Evaluating the Impact of Feed-forward Patient Reported Outcomes Data to Clinical Teams Managing Adults Living With MS in a Learning Health System for MS Research

Status
Terminated
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04907305
Enrollment
1594
Registered
2021-05-28
Start date
2021-11-02
Completion date
2024-02-19
Last updated
2024-06-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Multiple Sclerosis (MS)

Keywords

Multiple Sclerosis, Patient Reported Outcomes, Patient Determined Disease Steps, Learning Healthcare System

Brief summary

This Next Generation learning health system for Multiple Sclerosis (Next-Gen MS) study is a sub-study of the MS-LINK™ Outcomes Study (NCT04735406). The study aims to examine the effects of using feed forward Patient Reported Outcomes (PROs) data in real-world Multiple Sclerosis (MS) care settings. The study will be conducted within an emerging Learning Healthcare System (LHS).

Interventions

None listed

Sponsors

EMD Serono Research & Development Institute, Inc.
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Participants willing and able to provide written informed consent * Participants with clinical diagnosis of Multiple Sclerosis (MS)

Exclusion criteria

* None

Design outcomes

Primary

MeasureTime frame
Change From Baseline in Health-Related Quality of Life 14 Item (HR-QoL-14)Baseline up to 18 Months

Secondary

MeasureTime frame
Percentage of Participants with >=1-point Increase from Baseline in Patient Determined Disease Steps (PDDS) Sustained Via Consecutive Measures Over 3 MonthsBaseline up to 18 Months

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026